0 items USD 0.00Search
- Did you mean
- rejuvenation idiopathic arthrex
Your search for "Juvenile idiopathic arthritis" gave back 1470 results.
The global Enbrel (Etanercept) and Biosimilar market size is projected to grow from US$ 6211.9 million in 2022 to US$ 7862.4 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Enbrel (Etanercept) and Biosimilar market size is expected to reach $ 8122.5 million by 2029, rising at a market growth of 3.2% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Enbrel (Etanercept) and Biosimilar market size was valued at USD 6533.8 million in 2022 and is forecast to a readjusted size of USD 8122.5...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global Enbrel (Etanercept) Biosimilar market size was valued at USD 1283.1 million in 2022 and is forecast to a readjusted size of USD 1732.5...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and...
Catalog:
LPI
February 2023
Price: USD 3,660.00
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis. The “Etanercept...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Etanercept market size was valued at US$ million in 2023. With growing demand in downstream market, the Etanercept is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis. The global...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis. Highlights The...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
